Immune mediated disease | Observed | Rate ratio (95% CI) | P value |
---|---|---|---|
Addison’s disease | 18 | 1.82 (1.08-2.88) | 0.02 |
Ankylosing spondylitis | 34 | 1.55 (1.07-2.16) | 0.01 |
Autoimmune haemolytic anaemia | 11 | 1.87 (0.93-3.34) | 0.06 |
Chronic active hepatitis | 1 | 0.21 (0.01-1.2) | 0.14 |
Coeliac disease | 49 | 0.89 (0.66-1.18) | 0.48 |
Crohn’s disease | 133 | 1.32 (1.11-1.57) | 0.002 |
Dermatomyositis | 2 | 1.11 (0.13-4.02) | 0.83 |
Diabetes mellitus | 390 | 1.10 (0.99-1.22) | 0.067 |
Goodpasture’s syndrome | 2 | 3.12 (0.38-11.27) | 0.28 |
Hashimoto’s thyroiditis | 8 | 0.97 (0.42-1.91) | 0.93 |
Idiopathic thrombocytopenia purpura | 40 | 2.04 (1.45-2.78) | <0.001* |
Multiple sclerosis | 87 | 1 (0.8-1.24) | 0.97 |
Myasthenia gravis | 8 | 0.79 (0.34-1.55) | 0.61 |
Myxoedema | 823 | 1.02 (0.95-1.1) | 0.53 |
Pemphigoid | 9 | 1.03 (0.47-1.96) | 0.94 |
Pemphigus | 2 | 1.21 (0.15-4.37) | 0.91 |
Pernicious anaemia | 66 | 1.22 (0.95-1.56) | 0.12 |
Polyarteritis nodosa | 2 | 1.15 (0.14-4.15) | 0.85 |
Polymyositis | 6 | 1.72 (0.63-3.75) | 0.28 |
Primary biliary cirrhosis | 19 | 1.86 (1.12-2.9) | 0.01 |
Psoriasis | 122 | 1.35 (1.12-1.62) | 0.001* |
Rheumatoid arthritis | 483 | 1.44 (1.31-1.58) | <0.001* |
Scleroderma | 19 | 1.83 (1.1-2.85) | 0.012 |
Sjogren’s syndrome | 34 | 1.94 (1.35-2.72) | <0.001* |
Systematic lupus erythematosus | 80 | 3.5 (2.77-4.36) | <0.001* |
Thyrotoxicosis | 153 | 1.38 (1.16-1.62) | <0.001* |
Ulcerative colitis | 167 | 1.03 (0.88-1.2) | 0.71 |